Sizing up the Pregnancy and Lactation Labeling Rule: Understanding Challenges and Opportunities

The labeling rules governing how medication risks associated with pregnancy and lactation are displayed on product packaging and inserts have been under scrutiny for years. In response to growing concerns among healthcare professionals about the utility of the pregnancy labeling format, the U.S. Food and Drug Administration (FDA) implemented new rules to improve pregnancy safety labeling.

Download White Paper

You may also like:

White Paper

Learn more about the issue of polypharmacy and how payers can help address it, including:  Differing definitions of polypharmacy and the “Holy Trinity” interaction of CNS-affecting drugs 

View White Paper
Blog Post

Returning from The American Pharmacists Association’s (APhA) recent Annual Meeting & Exposition in Seattle, WA, I feel invigorated and excited about what is happening in our natio...

View Blog Post
Blog Post

Throughout life, genomes are stable, but gene expression and their function may vary as we age. The biggest challenge to clinicians is gene expression and ontogeny in children. Understanding pediatric ...

View Blog Post

RxPerts Academy

Stay in the Know

Sign up to start receiving notifications via email of our upcoming webinars!

Sign Up